Cafepharma Today

April 26 2024 - Why the obesity drug market is about to get a lot more crowded
Why the obesity drug market is about to get a lot more crowded
Pfizer hemophilia gene therapy arrives in US to uncertain future
AbbVie lifts profit forecast after Skyrizi sales beat expectations
Walgreens rolls out gene, cell therapy services
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi-Aventis shares jump 5.2% amid reports of CEO change
Marketwatch
Wednesday, September 10, 2008 - 8:45am
tags:
How to Trade Dendreon
The Street.com
Wednesday, September 10, 2008 - 8:39am
tags:
Takeda Hasn't Bid for Alizyme, Won't Discuss Future
Bloomberg
Wednesday, September 10, 2008 - 8:39am
tags:
Pfizer Inked Secret Accord With Quigley, U.S. Says
Bloomberg
Wednesday, September 10, 2008 - 8:38am
tags:
Alpharma reports positive results from trial of morphine-based painkiller
Yahoo/AP
Tuesday, September 9, 2008 - 10:29pm
tags:
Sepracor Reliant on Lunesta
Yahoo/Zacks.com
Tuesday, September 9, 2008 - 10:28pm
tags:
Mylan Drops After Keeping Drug Unit, Refinancing Debt
Bloomberg
Tuesday, September 9, 2008 - 10:28pm
tags:
Genzyme recalls single lot of kidney transplant drug
Bizjournals.com
Tuesday, September 9, 2008 - 10:25pm
tags:
Byetta Pressed By Bad Press
Forbes
Tuesday, September 9, 2008 - 10:23pm
tags:
Drug Duo Combines Its Way Toward an Approval
Motley Fool
Tuesday, September 9, 2008 - 10:22pm
tags:
Vioxx Shareholder Lawsuit: Back On!
WSJ Online
Tuesday, September 9, 2008 - 10:22pm
tags:
Viehbacher to join Sanofi-Aventis
FT.com
Tuesday, September 9, 2008 - 10:20pm
tags:
Sector Snap: Diabetes drug developers
Yahoo/AP
Tuesday, September 9, 2008 - 10:19pm
tags:
Sanofi Gains on Report Glaxo's Viehbacher Will Take a Top Post
Bloomberg
Tuesday, September 9, 2008 - 11:22am
tags:
Nabi gets NIH funding for staph infection vaccine
Yahoo/AP
Tuesday, September 9, 2008 - 11:20am
tags:
Pfizer pulls application for antibiotic, plans additional late-stage clinical trial
Yahoo/AP
Tuesday, September 9, 2008 - 9:32am
tags:
High Court May Immunize Big Pharma
In these Times
Tuesday, September 9, 2008 - 9:22am
tags:
Traders Boost Bayer on Pfizer Deal Speculation
WSJ Online
Tuesday, September 9, 2008 - 9:18am
tags:
Amylin says Byetta outperformed Januvia in trial
Reuters
Tuesday, September 9, 2008 - 8:47am
tags:
Five New Studies at Major Medical Meeting Further Demonstrate Clinical Experience for JANUVIA
Yahoo
Tuesday, September 9, 2008 - 8:46am
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
Drug Channels
The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels

Latest Jobs

Account Executive - Hospice
Kansas City, MO, 64190
Agape Care Group
Area Manager-Specialty Mid-South
Fields, OR, 97710
CSL Behring
Account Executive - Hospice
Garden City, MO, 64747
Agape Care Group
Account Executive - Hospice
Holden, MO, 64040
Agape Care Group
Account Executive - Hospice
Harrisonville, MO, 64701
Agape Care Group
Account Executive - Hospice
Freeman, MO, 64746
Agape Care Group
Account Executive - Hospice
Higginsville, MO, 64037
Agape Care Group
Area Manager, Immunology West
Coffeyville, KS, 67337
CSL Behring
Area Manager-Immunology Southeast
Fields, OR, 97710
CSL Behring
Area Manager-Specialty, Delaware Valley
Fields, OR, 97710
CSL Behring
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information